Naima Ortolan

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Positron Emission Tomography

Sentinel Lymph Node

Top Venues

Diagnostics (Basel, Switzerland)

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Luca Urso, Corrado Cittanti, Luigi Manco, Naima Ortolan, Francesca Borgia, Antonio Malorgio, Giovanni Scribano, Edoardo Mastella, Massimo Guidoboni, Antonio Stefanelli, Alessandro Turra, Mirco Bartolomei
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18 F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer. Diagnostics (Basel, Switzerland) 14 (12) (2024)
Luca Urso, Corrado Cittanti, Luigi Manco, Naima Ortolan, Francesca Borgia, Antonio Malorgio, Giovanni Scribano, Edoardo Mastella, Massimo Guidoboni, Antonio Stefanelli, Alessandro Turra, Mirco Bartolomei
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18 F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer. Diagnostics (Basel, Switzerland) 14 (12) (2024)
Luca Urso, Angelo Castello, Giorgio Treglia, Stefano Panareo, Alberto Nieri, Ilaria Rambaldi, Matteo Caracciolo, Naima Ortolan, Licia Uccelli, Corrado Cittanti, Massimo Castellani, Mirco Bartolomei
Relevance of Volumetric Parameters Applied to [ 68 Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT. Diagnostics (Basel, Switzerland) 13 (4) (2023)
Francesco Dondi, Achille Lazzarato, Joana Gorica, Priscilla Guglielmo, Francesca Borgia, Rossella Filice, Antonio Vento, Sara Pacella, Riccardo Camedda, Matteo Caracciolo, Maria Silvia De Feo, Paolo Mammucci, Viviana Frantellizzi, Naima Ortolan, Elisa Fiasconaro, Luca Urso, Laura Evangelista, Riccardo Laudicella, Giulia Santo, null null
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score. Life (Basel, Switzerland) 13 (3) (2023)
Luca Urso, Angelo Castello, Giorgio Treglia, Stefano Panareo, Alberto Nieri, Ilaria Rambaldi, Matteo Caracciolo, Naima Ortolan, Licia Uccelli, Corrado Cittanti, Massimo Castellani, Mirco Bartolomei
Relevance of Volumetric Parameters Applied to [ 68 Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT. Diagnostics (Basel, Switzerland) 13 (4) (2023)
Francesco Dondi, Achille Lazzarato, Joana Gorica, Priscilla Guglielmo, Francesca Borgia, Rossella Filice, Antonio Vento, Sara Pacella, Riccardo Camedda, Matteo Caracciolo, Maria Silvia De Feo, Paolo Mammucci, Viviana Frantellizzi, Naima Ortolan, Elisa Fiasconaro, Luca Urso, Laura Evangelista, Riccardo Laudicella, Giulia Santo, null null
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score. Life (Basel, Switzerland) 13 (3) (2023)
Luca Urso, Angelo Castello, Giorgio Treglia, Stefano Panareo, Alberto Nieri, Ilaria Rambaldi, Matteo Caracciolo, Naima Ortolan, Licia Uccelli, Corrado Cittanti, Massimo Castellani, Mirco Bartolomei
Relevance of Volumetric Parameters Applied to [ 68 Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT. Diagnostics (Basel, Switzerland) 13 (4) (2023)
Francesco Dondi, Achille Lazzarato, Joana Gorica, Priscilla Guglielmo, Francesca Borgia, Rossella Filice, Antonio Vento, Sara Pacella, Riccardo Camedda, Matteo Caracciolo, Maria Silvia De Feo, Paolo Mammucci, Viviana Frantellizzi, Naima Ortolan, Elisa Fiasconaro, Luca Urso, Laura Evangelista, Riccardo Laudicella, Giulia Santo, null null
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score. Life (Basel, Switzerland) 13 (3) (2023)
Natale Quartuccio, Pierpaolo Alongi, Luca Urso, Naima Ortolan, Francesca Borgia, Mirco Bartolomei, Gaspare Arnone, Laura Evangelista
18 F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy. Cancers 15 (10) (2023)
Luca Urso, Laura Evangelista, Pierpaolo Alongi, Natale Quartuccio, Corrado Cittanti, Ilaria Rambaldi, Naima Ortolan, Francesca Borgia, Alberto Nieri, Licia Uccelli, Alessio Schirone, Stefano Panareo, Gaspare Arnone, Mirco Bartolomei
The Value of Semiquantitative Parameters Derived from 18 F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer. Cancers 14 (23) (2022)
Luca Urso, Laura Evangelista, Pierpaolo Alongi, Natale Quartuccio, Corrado Cittanti, Ilaria Rambaldi, Naima Ortolan, Francesca Borgia, Alberto Nieri, Licia Uccelli, Alessio Schirone, Stefano Panareo, Gaspare Arnone, Mirco Bartolomei
The Value of Semiquantitative Parameters Derived from 18 F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer. Cancers 14 (23) (2022)
Matteo Caracciolo, Angelo Castello, Luca Urso, Francesca Borgia, Naima Ortolan, Licia Uccelli, Corrado Cittanti, Massimo Castellani, Mirco Bartolomei, Massimo Lazzeri, Egesta Lopci
The Role of [ 68 Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review. Cancers 14 (20) (2022)
Luca Urso, Laura Evangelista, Pierpaolo Alongi, Natale Quartuccio, Corrado Cittanti, Ilaria Rambaldi, Naima Ortolan, Francesca Borgia, Alberto Nieri, Licia Uccelli, Alessio Schirone, Stefano Panareo, Gaspare Arnone, Mirco Bartolomei
The Value of Semiquantitative Parameters Derived from 18 F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer. Cancers 14 (23) (2022)